Get In Touch

Global Mice Model Market: Snapshot 

Biomedical research has taken a front seat in the healthcare and pharmaceutical industries, to a point where a nation’s research and development landscape can be gauged by its level of investment in biomedical research. The past decade has consequently witnessed a staggering rise in biomedical research in most countries, both developed and developing. A significant part of this research investment typically goes into animal models, more specifically, mice models. This forms the primary driver for the global mice models market.

Another factor promoting the increased use of mice models is the recent number of improvements that have been made in mice models. These improvements have not only enhanced their utility in current applications, but also increased the overall scope of applications for mice models. Biomedical research can use mice models for increasingly complex diseases, such as the use of mutated mice models for studying the ALS disease, or the use of advanced mice models to understand lung injury repair.

The factors above and similar ones that promote the use of mice models are responsible for imparting a positive growth rate to the global mice models market, which is expected to be valued at US$1.79 bn by the end of 2023.

 

mice-model-market

 

Demand for Mice Models in North America Remains High

44.9% of the global market for mice models is expected to be held by North America in 2023, in terms of revenue. Europe at the same time is expected to emerge as the second-leading market for mice models, followed closely by Asia Pacific. North America and Europe have an established pharmaceutical industry and an advanced biosciences research field. Both regions are still showing a high demand for mice models that are meant to be used in advanced drug discovery processes and other medical research.

However, their overall share in the market value has dropped since 2014, owing to the significantly high demand for mice models in Asia Pacific. This region is showing an especially high demand for knockout and transgenic mice models. Close to half of the global mice models business in the world for these types is taken up by the Asia Pacific countries of China, India, Malaysia, and Singapore.

Inbred Mice Models Continue to Show High Demand, Demand for Hybrid Models on the Rise

Based on model types, the global market for mice models is expected to progress at a CAGR of 6.4% from 2015 to 2023, ending at US$1.79 bn by the end of 2023. Among the various mice model types, inbred mice models have consistently been the popular ones, owing to the ease with which scientists can reproduce the data and the overall cost effective system of obtaining inbred mice models. Additionally, the size of samples in inbred mice models can be considerably smaller than their outbred counterparts.

However, the demand for congenic or hybrid mice models is expected to rise significantly over the coming years owing to a high preference for them in the expanding cardiovascular research. Transgenic mice models are the second most popular models in the world. They possess a high volume of research capability in the fields of angiogenesis, breast cancer, and Alzheimer’s disease.

The key providers of mice models from a global standpoint include Charles River Laboratories, The Jackson Laboratory, Harlan Laboratories, and Taconic Biosciences.

Global Mice Model Market: Brief Account 

The world mice model market is envisaged to be primarily advantaged by the growing investments in biomedical research which plays a vital role in pharmaceutical and healthcare sectors. Investment in biomedical research is considered to be a crucial determinant for gauging the level of research and development achieved by a nation. Mice models could attract a decent demand in such investments, which could eventually increase in the near future because of their diversified applications. 

Recently, a mice model with fragile X syndrome was used to test the effect of metformin, a type 2 diabetes drug. The results revealed a reversal of brain and behavioral abnormalities in the mice model. According to the report offered herewith, the world mice model market could find extensive opportunities birthing from different type, specialty, and services segments. 

The authors of the report have provided a vast study of the world mice model market in terms of several aspects such as business opportunities, restraining factors, key drivers, and vendor landscape. Readers are expected to gain a significant understanding of the market and plan for a better position therein. 

Global Mice Model Market: Trends and Opportunities 

The employment of mice models by the ALS Association for deep research on the disease amyotrophic lateral sclerosis (ALS) is regarded as a fine instance of the rising demand in the market. This is evident of the latest developments in various services and types of mice model that are anticipated to improve existing research procedures. The penetration of mice models in several medical research domains could be another factor strengthening the demand in the market. 

Irrigation assay system, computer-generated simulations, and other alternative solutions incorporating a streamlined procedure and faster conclusion development process are foretold to impede the growth of the world mice model market. This could be owing to the efforts to reduce or restrict the requirement of animal models. However, studies of advanced diseases incorporating the application of new mice models are prognosticated to add to the growth of the market. Lung disease repair and other cutting-edge researches also cover the use of innovative mice models. 

Global Mice Model Market: Geographical Analysis 

Expert analysts foresee the international mice model market to mainly operate in key geographies such as Asia Pacific, Europe, North America, the Middle East and Africa, Latin America, and Rest of the World. In respect of revenue, North America could take a leading position in the market with a significant share secured under its belt. Narrowly followed by Asia Pacific, Europe is anticipated to be another region cementing a strong position in the market. Both these markets could be riding on their sophisticated biosciences research and well-established pharmaceutical sectors. 

Nevertheless, the staggering shares in North America and Europe are predicted to lose their grip on the international mice model market in future on account a telling demand in Asia Pacific. Nearly half of the business for transgenic and knockout mice models could be taken up by Asia Pacific in Singapore, Malaysia, India, and China. 

Global Mice Model Market: Companies Mentioned 

Some of the important players studied in this research publication could be Harlan Laboratories, Inc., GenOway S.A., Deltagen, Inc., Crescendo Biologics Limited, and Charles River Laboratories. A quality analysis of the key companies operating in the worldwide mice model market is expected to help participants to stay watchful and make informed decisions in their business operations. 

The global mice model market is segmented into the following categories: 

Global Mice Model Market by Type 

  • Transgenic Mice Model
  • Hybrid/Congenic Mice Model
  • Knockout Mice Model
  • Carcinogen-induced and Spontaneous Mice Model
  • Outbred Mice Model
  • Inbred Mice Model
  • Transplantation Mice Model
  • Conditioned/Surgically Modified Mice Model 

Global Mice Model Market by Specialty 

  • Immunology
  • Central Nervous System
  • Oncology
  • Cardiovascular
  • Diabetes
  • Metabolism and Regulation 

Global Mice Model Market by Services 

  • Breeding and Rederivation Services
  • Cryopreservation and Cryorecovery Services
  • Quarantine Services
  • Genetic Testing Services
  • Model In-licensing Services
  • In vivo and In vitro Pharmacology Services
  • Genetically Engineered Model Services
  • Surgical and Line Rescue 

Global Mice Model Market by Geography 

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Rest of Europe
  • Asia Pacific (APAC)
    • Japan
    • China
    • Rest of APAC
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East and North Africa (MENA)
    • Saudi Arabia
    • A.E.
    • Israel
    • Rest of MENA
  • Rest of the World (RoW) 

This report gives access to decisive data, such as: 

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for the coming years 

Key highlights of this report include: 

  • Overview of key market forces propelling and restraining market growth
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors
  • An array of graphics and SWOT analysis of major industry segments
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

 
Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
      1.2.1 Secondary Research
      1.2.2 Primary Research
1.3 Market Segmentation
1.4 Assumptions and Stipulations
 
Chapter 2 Executive Summary
2.1 Global Mice Consumption, 2013
2.2 Market Snapshot: Global Mice Model Market (2014 and 2023E)
2.3 Global Mice Model Market, by Type, 2014 (USD Million)
2.4 Global Mice Model Market, by Application, 2014 (USD Million)
2.5 Global Mice Model Market, by Services, 2014 (USD Million)
2.6 Comparative Analysis: Global Mice Model Market Revenue, by Geography, 2014 and 2023E (Value %)
 
Chapter 3 Global Mice Model Market: Market Overview
3.1 Overview
      3.1.1 Proportion of Mice as Compared to Total Animal Used in Research Globally (Value %), 2011
3.2 End-users of Mice Models
      3.2.1 End-user Analysis of Mice Model Market (Value %), 2013
3.3 Market Dynamics
      3.3.1 Drivers
              3.3.1.1 Growing investment in biomedical research
              3.3.1.2 Biomedical Research Growth Rate, 2007–2012, (%)
              3.3.1.3 Growing number of advanced mice model would increase applicability and acceptability
              3.3.1.4 Personalized in vivo analysis mice models would fuel demand for mice models in personalized medicine
      3.3.2 Restraints
              3.3.2.1 Rising concern about animal use across the globe would restrain the market
              3.3.2.2 Development of alternative technologies
      3.3.3 Opportunities
              3.3.3.1 Countries in Asia offer immense growth opportunities in the mice model market
3.4 Event Impact Assessment: Mice Model Market
3.5 Market Attractiveness Analysis: Global Mice Model Market
      3.5.1 Mice Model Market Analysis: The U.S. and China
      3.5.2 Market Attractiveness Analysis: Global Mice Model Market, by Geography      
      3.5.3 Growth-Share Matrix Analysis: Global Mice Model Market, by Type
3.6 Competitive Landscape
      3.6.1 Global Market Share Analysis, by Key Players, 2013 (Value %)
      3.6.2 Global Market Share Analysis, by Key Players, 2014 (Value %)
      3.6.3 Heat Map Analysis, by Key Geography, 2014 (Market Share)
      3.6.4 Heat Map Analysis, by Key Geography, 2014 (Market Growth)
 
Chapter 4 Global Mice Model Market, by Type
4.1 Overview
      4.1.1 Global Mice Model Market, by Type, 2013–2014 (USD Million)
      4.1.2 Global Mice Model Market, by Model Type, 2015E–2023E (USD Million)
4.2 Transgenic Mice Model
      4.2.1 Transgenic Mice Applications in Various Specialties (%)
      4.2.2 Global Transgenic Mice Model Market, 2013–2023E (USD Million)
4.3 Hybrid/Congenic Mice Model
      4.3.1 Global Hybrid/Congenic Mice Model Market, 2013–2023E (USD Million)
4.4 Knockout Mice Model
      4.4.1 Knockout Mice Applications in Various Specialties, 2014 (%)
      4.4.2 Global Knockout Mice Model Market, 2013–2023E (USD Million)
4.5 Carcinogen-induced and Spontaneous Mice Model
      4.5.1 Global Carcinogen-induced and Spontaneous Mice Model Market, 2013–2023E (USD Million)
4.6 Outbred Mice Model
      4.6.1 Global Outbred Mice Model Market, 2013–2023E (USD Million)
4.7 Inbred Mice Model
              4.7.1.1 Inbred Mice Applications in various Specialties (%), 2014
              4.7.1.2 Global Inbred Mice Model Market, 2013–2023E (USD Million)
4.8 Transplantation Mice Model
      4.8.1 Global Transplantation Mice Model Market, 2013–2023E (USD Million)
4.9 Conditioned/Surgically Modified Mice Model
      4.9.1 Global Conditioned/Surgically Modified Mice Model Market, 2013–2023E (USD Million)
 
Chapter 5 Global Mice Model Market, by Specialty
5.1 Overview
      5.1.1 Global Mice Model Market, by Application, 2013–2014 (USD Million)
      5.1.2 Global Mice Model Market, by Application, 2015E–2023E (USD Million)
5.2 Immunology
      5.2.1 Global Immunology Mice Model Market, 2013–2023E (USD Million)
      5.2.2 Number of Immunology Mice Models, by Major Companies
      5.2.3 Immunology Mice Model Market Share, by Model Type, 2014
5.3 Central Nervous System (CNS)
      5.3.1 Global CNS Mice Model Market, 2013–2023E (USD Million)
      5.3.2 Number of CNS Mice Models, by Major Companies
      5.3.3 CNS Mice Model Market Share, by Model Type, 2014
5.4 Oncology
      5.4.1 Global Oncology Mice Model Market, 2013–2023E (USD Million)
      5.4.2 Number of Oncology Mice Models, by Major Companies
      5.4.3 Oncology Mice Model Market Share, by Model Type, 2014
5.5 Cardiovascular
      5.5.1 Global Cardiovascular Mice Model Market, 2013–2023E (USD Million)
      5.5.2 Number of Cardiovascular Mice Models, by Major Companies
      5.5.3 Cardiovascular Mice Model Market Share, by Model Type, 2014
5.6 Diabetes
      5.6.1 Global Diabetes Mice Model Market, 2013–2023E (USD Million)
      5.6.2 Number of Diabetes Mice Models, by Major Companies
      5.6.3 Diabetes Mice Model Market Share, by Model Type, 2014
5.7 Metabolism & Regulation
      5.7.1 Global Metabolism & Regulation Mice Model Market, 2013–2023E (USD Million)
      5.7.2 Metabolism & Regulation Mice Models Market Share, by Model Type, 2014
 
Chapter 6 Global Mice Model Market, by Services
6.1 Overview
      6.1.1 Global Mice Model Market, by Services, 2013–2014 (USD Million)
      6.1.2 Global Mice Model Market, by Services, 2015E–2023E (USD Million)
6.2 Breeding and Rederivation Services
      6.2.1 Global Breeding and Rederivation Services Market, 2013–2023E (USD Million)
6.3 Cryopreservation and Cryorecovery Services
      6.3.1 Global Cryopreservation and Cryorecovery Services Market, 2013–2023E (USD Million)
6.4 Quarantine Services
      6.4.1 Global Quarantine Services Market, 2013–2023E (USD Million)
6.5 Genetic Testing Services
      6.5.1 Global Genetic Testing Services Market, 2013–2023E (USD Million)
6.6 Model In-licensing Services
      6.6.1 Global Model In-licensing Market, 2013–2023E (USD Million)
6.7 In vivo and In vitro Pharmacology Services
      6.7.1 Global In vivo and In vitro Pharmacology Services Market, 2013–2023E (USD Million)
6.8 Genetically Engineered Model Services
      6.8.1 Genetically Engineered Model Services
6.9 Other Services (Surgical and Line Rescue)
      6.9.1 Global Other Services Market, 2013–2023E (USD Million)
 
Chapter 7 Global Mice Model Market, by Geography
7.1 Overview
      7.1.1 Mice Model Market Share Index, 2014 (On Scale of 1 to 5)
      7.1.2 Global Mice Model Market, Growth Index, 2015–2023 (On a Scale of 1 to 5)
      7.1.3 Global Mice Model Market Revenue, by Geography, 2013–2023 (USD Million)
7.2 North America
      7.2.1 North America Population, GDP, and Health care Expenditure, 2011–2013
      7.2.2 North America Mice Model Market Revenue, 2013–2023E (USD Million
      7.2.3 U.S.
              7.2.3.1 U.S. Mice Model Market, 2013–2023E (USD Million)
      7.2.4 Canada
              7.2.4.1 Comparative Analysis: Proportion of Animals Used in Research in Canada, 2011 and 2012 (Value %)
              7.2.4.2 Canada Mice Model Market, 2013–2023E (USD Million)
7.3 Europe
      7.3.1 Europe Population, GDP, and Health care Expenditure, 2011–2013
      7.3.2 Europe Mice Model Market Revenue, 2013–2023E (USD Million)
      7.3.3 Germany
              7.3.3.1 Germany Mice Model Market Revenue, 2013–2023E (USD Million)
      7.3.4 U.K.
              7.3.4.1 U.K. Mice Model Market Revenue, 2013–2023E (USD Million)
      7.3.5 Rest of Europe
              7.3.5.1 Rest of Europe Mice Model Market Revenue, 2013–2023E (USD Million)
7.4 Asia Pacific
      7.4.1 Asia Pacific Population, GDP, and Healthcare Expenditure, 2011–2013
      7.4.2 Asia Pacific Mice Model Market Revenue, 2013–2023E (USD Million)
      7.4.3 Japan
              7.4.3.1 Japan Mice Model Market, 2013–2023E (USD Million)
      7.4.4 China
              7.4.4.1 China Mice Model Market, 2013–2023E (USD Million)
      7.4.5 Rest of Asia Pacific
              7.4.5.1 Rest of Asia Pacific Mice Model Market, 2013–2023E (USD Million)
7.5 Latin America
      7.5.1 Latin America Population, GDP, and Health care Expenditure, 2011 – 2013
      7.5.2 Latin America Mice Model Market, 2013–2023E (USD Million)
      7.5.3 Brazil
              7.5.3.1 Brazil Mice Model Market, 2013–2023E (USD Million)
      7.5.4 Mexico
              7.5.4.1 Mexico Mice Model Market, 2013–2023E (USD Million)
      7.5.5 Rest of Latin America
              7.5.5.1 Rest of Latin America Mice Model Market, 2013–2023E (USD Million)
7.6 Middle East & North Africa (MENA)
      7.6.1 MENA Mice Model Market, 2013–2023E (USD Million)
      7.6.2 Saudi Arabia (KSA)
              7.6.2.1 Saudi Arabia Mice Model Market, 2013–2023E (USD Million)
      7.6.3 UAE
              7.6.3.1 UAE Mice Model Market, 2013–2023E (USD Million)
      7.6.4 Israel
              7.6.4.1 Israel Mice Model Market, 2013–2023E (USD Million)
      7.6.5 Rest of MENA
              7.6.5.1 Rest of MENA Mice Model Market, 2013–2023E (USD Million)
7.7 Rest of the World (RoW)
      7.7.1 RoW Population, GDP, and Health care Expenditure, 2011–2013
      7.7.2 Rest of World Mice Model Market, 2013–2023E (USD Million)
 
Chapter 8 Recommendations
8.1 Focus on collaborations with contract research organizations or strengthening in-house research capabilities
8.2 Sustaining pricing pressures in a declining global economic scenario
8.3 Investing in emerging markets such as India, China, and Brazil
 
Chapter 9 Company Profiles
9.1 Charles River Laboratories International, Inc.
      9.1.1 Company Overview
      9.1.2 Financial Overview
      9.1.3 Product Portfolio
      9.1.4 Business Strategies
      9.1.5 Recent Developments
9.2 Crescendo Biologics Limited
      9.2.1 Company Overview
      9.2.2 Financial Overview
      9.2.3 Product Portfolio
      9.2.4 Business Strategies
      9.2.5 Recent Developments
9.3 Deltagen, Inc.
      9.3.1 Company Overview
      9.3.2 Financial Overview
      9.3.3 Product Portfolio
      9.3.4 Business Strategies
      9.3.5 Recent Developments
9.4 genOway S.A.
      9.4.1 Company Overview
      9.4.2 Financial Overview
      9.4.3 Product Portfolio
      9.4.4 Business Strategies
      9.4.5 Recent Developments
9.5 Harbour Antibodies BV
      9.5.1 Company Overview
      9.5.2 Financial Overview
      9.5.3 Product Portfolio
      9.5.4 Business Strategies
      9.5.5 Recent Developments
9.6 Harlan Laboratories, Inc.
      9.6.1 Company Overview
      9.6.2 Financial Overview
      9.6.3 Product Portfolio
      9.6.4 Business Strategies
      9.6.5 Recent Developments
9.7 ImmunoGenes AG
      9.7.1 Company Overview
      9.7.2 Financial Overview
      9.7.3 Product Portfolio
      9.7.4 Business Strategies
      9.7.5 Recent Developments
9.8 SAGE Labs
      9.8.1 Company Overview
      9.8.2 Financial Overview
      9.8.3 Product Portfolio
      9.8.4 Business Strategies
      9.8.5 Recent Developments
9.9 The Jackson Laboratory
      9.9.1 Company Overview
      9.9.2 Financial Overview
      9.9.3 Product Portfolio
      9.9.4 Business Strategies
      9.9.5 Recent Developments
9.10 Taconic Biosciences, Inc.
      9.10.1 Company Overview
      9.10.2 Financial Overview
      9.10.3 Product Portfolio
      9.10.4 Business Strategies
      9.10.5 Recent Developments
9.11 TransGenic, Inc.
      9.11.1 Company Overview
      9.11.2 Financial Overview
      9.11.3 Product Portfolio
      9.11.4 Business Strategies
      9.11.5 Recent Developments
List of Tables
 
TABLE 1 Global Mice Consumption, 2013
TABLE 2 Market Snapshot: Global Mice Model Market (2014 and 2023E )
TABLE 3 Proportion of Mice as Compared to Total Animal Used in Research Globally (Value %), 2011
TABLE 4 End-user Analysis of Mice Model Market (Value %), 2013
TABLE 5 Global Mice Model Market, by Type, 2013–2014 (USD Million)
TABLE 6 Global Mice Model Market, by Model Type, 2015E–2023E (USD Million)
TABLE 7 Global Mice Model Market, by Application, 2013–2014 (USD Million)
TABLE 8 Global Mice Model Market, by Application, 2015E–2023E (USD Million)
TABLE 9 Global Mice Model Market, by Services, 2013–2014 (USD Million)
TABLE 10 Global Mice Model Market, by Services, 2015E–2023E (USD Million)
TABLE 11 Global Mice Model Market Revenue, by Geography, 2013–2023 (USD Million)
TABLE 12 North America Population, GDP, and Health care Expenditure, 2011–2013
TABLE 13 Europe Population, GDP, and Health care Expenditure, 2011–2013
TABLE 14 Europe Mice Model Market Revenue, 2013–2023E (USD Million)
TABLE 15 Asia Pacific Population, GDP, and Healthcare Expenditure, 2011–2013
TABLE 16 Asia Pacific Mice Model Market Revenue, 2013–2023E (USD Million)
TABLE 17 Latin America Population, GDP, and Health care Expenditure, 2011–2013
TABLE 18 Latin America Mice Model Market, 2013–2023E (USD Million)
TABLE 19 MENA Mice Model Market, 2013–2023E (USD Million)
TABLE 20 Row Population, GDP, and Health care Expenditure, 2011–2013
List of Figures
 
FIG. 1 Global Mice Model Market Segmentation
FIG. 2 Global Mice Model Market, By Type, 2014 (USD Million)
FIG. 3 Global Mice Model Market, By Application, 2014 (USD Million)
FIG. 4 Global Mice Model Market, By Services, 2014 (USD Million)
FIG. 5 Comparative Analysis: Global Mice Model Market Revenue, by Geography, 2014 and 2023E (Value %)
FIG. 6 Biomedical Research Growth Rate, 2007–2012, (%)
FIG. 7 Mice Model Market Analysis: The U.S. and China, 2014
FIG. 8 Market Attractiveness Analysis: Global Mice Model Market, by Geography
FIG. 9 Growth-Share Matrix Analysis: Global Mice Model Market, by Type
FIG. 10 Market Share Analysis: Global Mice Model Market, 2013 (Value %)
FIG. 11 Market Share Analysis: Global Mice Model Market, 2014 (Value %)
FIG. 12 Heat Map Analysis, by Key Geography, 2014 (Market Share)
FIG. 13 Heat Map Analysis, by Key Geography, 2014 (Market Growth)
FIG. 14 Transgenic Mice Applications in Various Specialties (%), 2014
FIG. 15 Transgenic Mice Model Market, 2013–2023E (USD Million)
FIG. 16 Hybrid/Congenic Mice Model Market, 2013–2023E (USD Million)
FIG. 17 Knockout Mice Applications in Various Specialties, 2014 (%)
FIG. 18 Knockout Mice Model Market, 2013–2023E (USD Million)
FIG. 19 Carcinogen-induced and Spontaneous Mice Model Market, 2013–2023E (USD Million)
FIG. 20 Outbred Mice Model Market, 2013–2023E (USD Million)
FIG. 21 Inbred Mice Applications in various Specialties (%), 2014
FIG. 22 Inbred Mice Model Market, 2013–2023E (USD Million)
FIG. 23 Transplantation Mice Model Market, 2013–2023E (USD Million)
FIG. 24 Conditioned/Surgically Modified Mice Model Market, 2013–2023E (USD Million)
FIG. 25 Immunology Mice Models Market, 2013–2023E (USD Million)
FIG. 26 Immunology Mice Models, by Major Companies
FIG. 27 Immunology Mice Model Market Share, by Model Type, 2014
FIG. 28 Immunology Mice Models Market, 2013–2023E (USD Million)
FIG. 29 Number of CNS Mice Models, by Major Companies
FIG. 30 Mice Model Market Share, by Model Type, 2014
FIG. 31 Oncology Mice Models Market, 2013–2023E (USD Million)
FIG. 32 Number of CNS Mice Models, by Major Companies
FIG. 33 Oncology Mice Model Market Share, by Model Type, 2014
FIG. 34 Cardiovascular Mice Models Market, 2013–2023E (USD Million)
FIG. 35 Number of CNS Mice Models, by Major Companies
FIG. 36 Cardiovascular Mice Model Market Share, by Model Type, 2014
FIG. 37 Diabetes Mice Models Market, 2013–2023E (USD Million)
FIG. 38 Number of Diabetes Mice Models, by Major Companies
FIG. 39 Diabetes Mice Model Market Share, by Model Type, 2014
FIG. 40 Metabolism & Regulation Mice Models Market, 2013–2023E (USD Million)
FIG. 41 Metabolism & Regulation Mice Models Market Share, by Model Type, 2014
FIG. 42 Global Breeding and Rederivation Services Market, 2013–2023E (USD Million)
FIG. 43 Global Cryopreservation and Cryorecovery Services Market, 2013–2023E (USD Million)
FIG. 44 Global Quarantine Services Market, 2013–2023E (USD Million)
FIG. 45 Global Genetic Testing Services Market, 2013–2023E (USD Million)
FIG. 46 Global Model In-licensing Market, 2013–2023E (USD Million)
FIG. 47 Global In vivo and In vitro Pharmacology Services Market, 2013–2023E (USD Million)
FIG. 48 Genetically Engineered Model Services
FIG. 49 Global Other Services Market, 2013–2023E (USD Million)
FIG. 50 Mice Model Market Share Index, 2014 (On Scale of 1 to 5)
FIG. 51 Global Mice Model Market, Growth Index, 2015–2023 (On a Scale of 1 to 5)
FIG. 52 U.S. Mice Model Market, 2013–2023E (USD Million)
FIG. 53 Comparative Analysis: Proportion of Animals Used in Research in Canada, 2011 and 2012 (Value %)
FIG. 54 Canada Mice Model Market, 2013–2023E (USD Million)
FIG. 55 Germany Mice Model Market Revenue, 2013–2023E (USD Million)
FIG. 56 U.K. Mice Model Market Revenue, 2013–2023E (USD Million)
FIG. 57 Rest of Europe Market Revenue, 2013–2023E (USD Million)
FIG. 58 Japan Mice Model Market, 2013–2023E (USD Million)
FIG. 59 China Mice Model Market, 2013–2023E (USD Million)
FIG. 60 Rest of Asia Pacific Mice Model Market, 2013–2023E (USD Million)
FIG. 61 Brazil Mice Model Market, 2013–2023E (USD Million)
FIG. 62 Mexico Mice Model Market, 2013–2023E (USD Million)
FIG. 63 Rest of Latin America Mice Model Market, 2013–2023E (USD Million)
FIG. 64 Saudi Arabia Mice Model Market, 2013 – 2023E (USD Million)
FIG. 65 UAE Mice Model Market, 2013–2023E (USD Million)
FIG. 66 Israel Mice Model Market, 2013–2023E (USD Million)
FIG. 67 Rest of MENA Mice Model Market, 2013–2023E (USD Million)
FIG. 68 Rest of World Mice Model Market, 2013–2023E (USD Million)
FIG. 69 Charles River Laboratories International, Inc.: Annual Revenue, 2012–2014 (USD Million)
FIG. 70 Charles River Laboratories International, Inc.: Business Segments
FIG. 71 Charles River Laboratories International, Inc.: Financials, 2012–2014
FIG. 72 Deltagen, Inc.: Annual Revenue, 2012–2014 (USD Million)
FIG. 73 Deltagen, Inc.: Financials, 2012–2014 (USD Million)
FIG. 74 genOway S.A.: Annual Revenue, 2012–2014 (USD Million)
FIG. 75 genOway S.A.: Financials, 2012–2014 (USD Million)
FIG. 76 The Jackson Laboratory: Annual Revenue, 2012–2014 (USD million)
FIG. 77 The Jackson Laboratory: Financials, 2012–2014 (USD million)
FIG. 78 TransGenic, Inc.: Annual Revenue, 2012–2014 (USD million)
FIG. 79 TransGenic, Inc.: Financials, 2012–2014 (USD million)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Mice Model Market